Work

What are the common genetic mutations associated with leiomyosarcoma, and how do they influence treatment decisions?

Year: 2026

Type: article

Abstract: No direct evidence specifically links genetic mutations in leiomyosarcoma with tailored treatment decisions. However, mutations in BRCA1/2, ATRX, and TP53 may guide use of targeted therapies, emphasizing the role of comprehensive molecular profiling in management.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.23736597

Author: Tripdatabase

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7224128578

FWCI:

Cites:

Cited by:

Related to: 10